The deal with Altucel isn't finalized due to lack of financing. In theory, we are waiting for GNBT's PPS to appreciate so we can use fewer shares and dilute less. Thankfully, Altucell seems to be patient and they sound like they are good with the plan.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links